Alchemab Therapeutics (Alchemab), a biopharmaceutical company aiming to identify and develop naturally occurring therapeutic antibodies from resilient individuals, today announces it has entered a ...
Nussbaum, 71, was diagnosed two years ago with amyotrophic lateral sclerosis (ALS), a progressive disease also known as Lou Gehrig’s disease that attacks nerve cells that control muscles throughout ...